MA54889B1 - USE OF TELOMERASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASIA - Google Patents
USE OF TELOMERASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASIAInfo
- Publication number
- MA54889B1 MA54889B1 MA54889A MA54889A MA54889B1 MA 54889 B1 MA54889 B1 MA 54889B1 MA 54889 A MA54889 A MA 54889A MA 54889 A MA54889 A MA 54889A MA 54889 B1 MA54889 B1 MA 54889B1
- Authority
- MA
- Morocco
- Prior art keywords
- myeloproliferative
- telomerase inhibitors
- treatment
- myeloproliferative disorders
- neoplasia
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La présente invention concerne des procédés pour réduire la prolifération de cellules progénitrices néoplasiques et soulager des symptômes associés chez des individus diagnostiqués avec ou suspectés d'avoir des troubles myéloprolifératifs, tels que la thrombocytémie essentielle (te). La présente invention concerne en outre des procédés d'utilisation d'inhibiteurs de télomérase pour maintenir les numérations plaquettaires sanguines dans des plages relativement normales dans le sang d'individus diagnostiqués avec ou suspectés d'avoir des troubles myéloprolifératifs, tels que te.The present invention relates to methods for reducing the proliferation of neoplastic progenitor cells and alleviating associated symptoms in individuals diagnosed with or suspected of having myeloproliferative disorders, such as essential thrombocythemia (e). The present invention further relates to methods of using telomerase inhibitors to maintain blood platelet counts within relatively normal ranges in the blood of individuals diagnosed with or suspected of having myeloproliferative disorders, such as te.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/841,711 US9375485B2 (en) | 2012-12-07 | 2013-03-15 | Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms |
PCT/US2013/070437 WO2014088785A1 (en) | 2012-12-07 | 2013-11-15 | Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms |
US201513841711A | 2015-03-15 | 2015-03-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
MA54889A1 MA54889A1 (en) | 2022-10-31 |
MA54889B1 true MA54889B1 (en) | 2023-07-31 |
Family
ID=83995786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA54889A MA54889B1 (en) | 2013-03-15 | 2013-11-15 | USE OF TELOMERASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASIA |
Country Status (1)
Country | Link |
---|---|
MA (1) | MA54889B1 (en) |
-
2013
- 2013-11-15 MA MA54889A patent/MA54889B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
MA54889A1 (en) | 2022-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA45504A1 (en) | Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasias | |
MA35365B1 (en) | Ringed Pyrimidines substituted and their use | |
MA34248B1 (en) | SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES AND THEIR USE | |
MA35844B1 (en) | Pyrimidines and substituted ringed triazines and their use | |
MA38060A1 (en) | Amidazo [1,2-a] amino-substituted pyridincarboxamides and their use | |
MA39211B1 (en) | Tricyclic compounds as anti-cancer agents | |
WO2014153115A3 (en) | Compositions and methods for reprogramming hematopoietic stem cell lineages | |
MA38365A1 (en) | Ringed pyrimidines with trifluoromethyl substitution and corresponding use | |
PH12015500114A1 (en) | HUMAN ANTIBODIES TO GFRa3 AND METHODS OF USE THEREOF | |
EP2539351A4 (en) | Fluid for accommodating intraocular lenses | |
EA201400119A1 (en) | PHARMACEUTICAL COMPOSITION, METHODS OF TREATMENT AND THEIR APPLICATION | |
GB0711327D0 (en) | Diagnostic method | |
MA38925B1 (en) | Substituted phenylalanine derivatives | |
MX2014010940A (en) | The use of antithrombin in the treatment of pre-eclampsia. | |
MX2015010023A (en) | Anti-cd83 antibodies and use thereof. | |
NZ631639A (en) | Methods and compositions for treating and diagnosing acute myocardial infarction | |
MA54889B1 (en) | USE OF TELOMERASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASIA | |
WO2015134631A8 (en) | Compositions and methods for identifying b cell malignancies responsive to b cell depleting therapy | |
EA201491522A1 (en) | METHODS OF TREATING DISORDERS OF GAIT AND / OR BALANCE IN PATIENTS WITH MULTIPLE SCLEROSIS USING AMINOPYRIDINE | |
MX2015012381A (en) | Fungal immunogens and related materials and methods. | |
TR201818988T4 (en) | Methods for alleviating the symptoms of multiple sclerosis based on compositions containing apoaequorin. | |
EA201990799A1 (en) | USE OF TELOMERASE INHIBITORS FOR TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASMS | |
FR3011468B1 (en) | USE OF ODIPARCIL IN THE TREATMENT OF MUCOPOLYSACCHARIDOSE | |
朱琳 | Expression of Sema4D in patients with cerebral infarction and its clinical significance | |
MA35029B1 (en) | TREATMENT OF HEPATITIS C VIRUS INFECTION WITH ALISPORIVIR |